Courses

Obesity and Micronutrient Risks: The Double Burden of Malnutrition

How can physicians recognize and mitigate the double burden of malnutrition in patients with obesity?

Author(s): Dominique R Williams, MD, MPH, FOMA, Dipl, ABOM; Carley Rusch, PhD, RD, LDN

Program Date: 01 October 2026

Publication Date: 01 October 2026

Continuing Education Credits: This educational event is not eligible for healthcare professional continuing education

Course Description:

Patients with obesity may be at risk for undernutrition, micronutrient deficiencies, and loss of lean body mass, even when obesity treatment is clinically appropriate and effective. These nutritional vulnerabilities may be present before treatment begins and can be amplified during weight loss, particularly with GLP-1 receptor agonists and other therapies that reduce appetite, food intake, or gastrointestinal tolerance.

Using a case-based approach, this program examines the emerging concept of the "double burden of malnutrition" in obesity and highlights the clinical implications for patient care. Physicians will explore common nutritional risks, including inadequate protein intake, poor diet quality, and deficiencies in nutrients such as vitamin D, vitamin B12, and iron, while reviewing the impact of obesity treatment on dietary intake, body composition, and muscle health.

The program offers practical strategies for identifying at-risk patients, recognizing signs of undernutrition despite elevated BMI, and integrating proactive nutrition care into obesity management. The course emphasizes nutrition screening, laboratory assessment, dietitian collaboration, protein optimization, and targeted supplementation to support metabolic health, preserve muscle mass, and improve patient outcomes during weight-loss treatment.

Course Objectives:
  • Recognize risks of malnutrition in people with overweight/obesity, including during intentional weight loss, and understand why elevated BMI does not preclude undernutrition or micronutrient deficiencies. 
  • Describe the impact of obesity treatments on dietary intake, body composition, and muscle health
  • Identify key nutritional vulnerabilities during obesity treatment and how these risks may be amplified with caloric restriction and medication-related changes in appetite or digestion
Key Takeaways:
  • People with obesity may have baseline nutrition risks, and these risks can worsen during weight loss – even when treatment is clinically appropriate and effective
  • Reduction in calories during GLP-1 therapy can affect protein and micronutrients alongside energy intake, increasing the likelihood of deficiencies unless nutrition quality and density are addressed
  • As part of comprehensive obesity care, history and physical exam can help monitor body composition changes, as nutrition and physical activity support muscle health
  • Nutrition support must be proactive, not reactive. Multiple society guidelines emphasize:
    • Early screening
    • Individualized nutrition counseling (including dietitian involvement)
    • Targeted supplementation to reduce risks of malnutrition and sarcopenia during obesity treatment

Performance Indicators: N/A

Activity Code: N/A

Related Questions:
  • Can a person with obesity be malnourished?
    Yes. Malnutrition can occur in people with obesity when nutrient intake, protein intake, or nutrient absorption is insufficient to meet physiological needs. Elevated BMI does not rule out undernutrition, micronutrient deficiencies, muscle loss, or poor diet quality.
  • Why are micronutrient deficiencies a concern during obesity treatment?
    Many obesity treatments reduce appetite and overall food intake, which may lower the intake of vitamins, minerals, and protein. When calorie reduction is substantial, and nutrition quality is not optimized, deficiencies in nutrients such as vitamin D, vitamin B12, iron, calcium, and other micronutrients may become more likely.

Course Instructor Bio(s):

Dominique Williams, MD, MPH, FOMA, Dipl ABOM

Medical Director, Adult Nutrition 
Abbott Nutrition 
Columbus, OH, USA

Dr Williams is the Adult Nutrition Medical Director at Abbott, a global healthcare company. Her responsibilities include supporting the U.S. and global adult nutrition commercial operations, collaborating with the clinical project team on Abbott-sponsored clinical studies, and driving the development, submission, and execution of investigator-initiated studies, including research publication. She also leads the medical strategy and content review, including moderation for national and international advisory meetings and symposia with multi-disciplinary teams. 

Dominique is double board-certified in Obesity Medicine and Pediatrics. She is a dedicated educator and clinician with more than 20 years of experience in person-centered care, holistic mentoring, and curriculum development. In addition to her clinical work, she has been a mentor to medical students and resident physicians and serves as Adjunct Faculty at The Ohio State University College of Medicine. Dominique has publications on the topics of mentoring, equity-focused initiatives in medical education, nutrition therapy, and the care of people with obesity. She has also worked on several local and national initiatives to address health disparities. 

Dominique obtained her Bachelor of Science in Nutrition from Case Western Reserve University, MD from Wright State University School of Medicine, and MPH in Nutrition from the University of Massachusetts, Amherst.

Carley Rusch, PhD, RDN, LDN

Medical Science Liaison
Abbott Nutrition 
Columbus, OH, USA

Carley Rusch serves as a Medical Science Liaison in Medical Affairs & Research at Abbott, specializing in Adult Therapeutic Nutrition. Prior to joining Abbott, Dr Rusch completed her bachelor’s degree in Food Science and Human Nutrition at the University of Florida (UF), specializing in Dietetics. She earned her master’s degree and completed her dietetic internship through the MS-DI program at UF. During her dietetic training, she also served as a research coordinator on a variety of study protocols, including topics on gastrointestinal dysfunction, inflammation, pre- and probiotics, and the gut microbiome. She then worked as an inpatient dietitian at AdventHealth Orlando and served as a preceptor for its dietetic internship program. Her clinical experience spans a variety of disease states, such as cancer, gastrointestinal and neurological disorders, malnutrition, and critical care. 

Following her time working in clinical practice, Dr Rusch completed her PhD in Nutritional Sciences at UF. Her doctoral research investigated the effect of the Mediterranean diet on improving constipation and intestinal inflammation in Parkinson’s disease. During her graduate programs, she has taught multiple undergraduate and graduate courses on nutrition, metabolism, and research methods. In 2020, she was awarded the Recognized Young Dietitian of the Year by the Florida Academy of Nutrition and Dietetics. Dr Rusch has several publications in peer-reviewed journals and has been invited to present at national and international conferences.

Category
References:
  • Christensen S, et al. Obes Pillars. 2024;11:100121. 
  • Hong K, et al. Diabetes Metab Syndr Obes. 2026;19:574765.
  • Butsch WS, et al. Obes Pillars. 2025;15:100186. 
  • Kim JE, et al. Nutr Rev. 2016;74(3):210-224. 
  • Mozaffarian D, et al. Obesity (Silver Spring). 2025;33(8):1475-1503.